(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

appetite suppressants

$5 Billion U.S. Meal Replacements Market Survives GLP-1s Competition

April 22, 2025 Marketdata LLC has just released a new market study: “The U.S. Meal Replacements Market: Retail & MLM Channels”, April 2025. This 77-page report analyses the meal replacements and retail appetite suppressants market in the U.S. The $5.1 billion U.S. meal replacements market has held up fairly well the past few years, despite

$5 Billion U.S. Meal Replacements Market Survives GLP-1s Competition Read More »

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion

March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss

$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »

Meal Replacements Do Well During The Pandemic

March 7, 2021 Marketdata’s research to update its study: “The U.S. Weight Loss & Diet Control Market” continues. One of the key chapters in this upcoming report tracks the meal replacements (powdered shakes, nutrition bars) and appetite suppressants market (retail and MLM non-prescription diet pills). Meal replacements have done well in 2020. Diet pills, not

Meal Replacements Do Well During The Pandemic Read More »

Scroll to Top